NPPA and cardiac hypertrophy: The progression of chronic hypertension to cardiac hypertrophy and congestive heart failure is characterised by an increase in the biosynthesis and release of ANP from the atrial and ventricular myocytes and this serves an important protective mechanism contributing to natriuresis, increased urine volume and lowering of blood pressure [6, 7, 24].